A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma

Autor: Smith, SC, Sirohi, D, Ohe, C, McHugh, JB, Hornick, JL, Kalariya, J, Karia, S, Snape, K, Hodgson, SV, Cani, AK, Hovelson, D, Luthringer, DJ, Martignoni, G, Chen, Y-B, Tomlins, SA, Mehra, R, Amin, MB

AIMS: Fumarate hydratase (FH)-deficient renal cell carcinoma (RCC) is a high-grade, aggressive tubulopapillary carcinoma, arising predominantly in the setting of the hereditary leiomyomatosis-RCC syndrome of familial uterocutaneous leiomyomatosis and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::183097efab986d0702dbc97b247079fb

A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma.

Autor: Smith SC; Departments of Pathology and Urology, VCU School of Medicine, Richmond, VA, USA., Sirohi D; Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Ohe C; Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA., McHugh JB; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA., Hornick JL; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Kalariya J; BT Savani Kidney Hospital, Rajkot, India., Karia S; BT Savani Kidney Hospital, Rajkot, India., Snape K; St Georges Hospital, London, UK., Hodgson SV; St Georges Hospital, London, UK., Cani AK; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA., Hovelson D; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA., Luthringer DJ; Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Martignoni G; Department of Pathology and Public Health, University of Verona, Verona, Italy.; Department of Pathology, Pederzoli Hospital, Peschiera del Garda, Verona, Italy., Chen YB; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tomlins SA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.; Michigan Center for Translational Pathology, Department of Urology, Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA., Mehra R; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.; Michigan Center for Translational Pathology, Department of Urology, Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA., Amin MB; Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.

Publikováno v: Histopathology [Histopathology] 2017 Jul; Vol. 71 (1), pp. 42-52. Date of Electronic Publication: 2017 Apr 12.